Printer Friendly
The Free Library
14,800,529 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Industrialinfo.com Pharma Focus: Biotech Manufacturing Tech Profile.


HOUSTON -- Researched by Industrialinfo.com (Industrial Information Resources (1) The data and information assets of an organization, department or unit. See data administration.

(2) Another name for the Information Systems (IS) or Information Technology (IT) department. See IT.
, Incorporated; Houston, Texas “Houston” redirects here. For other uses, see Houston (disambiguation).
Houston (pronounced /'hjuːstən/) is the largest city in the state of Texas and the
). The biotech drug sector continues to advance, from an estimated $12 billion in 1990, to roughly $27 billion in 2004. This is in contrast to the nearly $270 billion spent annually for so-called "traditional" pharmaceuticals, or as referred to by those in the industry, "small molecule therapeutics." As discussed in Industrialinfo.com's 2005 Pharmaceutical Industry Forecast, although biopharmaceuticals comprise roughly only 5% of the world's prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug,  sales, they account for six of the top fifty selling drugs, 13% of new medicines approved by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 in the 1990s, and about 18% of all drugs in development.

For more information view the entire article by registering for free at http://www.industrialinfo.com/showNews.jsp?newsitemID=63582, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Information Resources (IIR IIR - Infinite Impulse Response ) is a Marketing Information Service company that has been in business for over 22 years. IIR is respected as a leader in providing comprehensive market information pertaining to the industrial processing, heavy manufacturing and energy related industries throughout the world. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 9, 2005
Words:199
Previous Article:Arrowhead's Warrants Delisted from Nasdaq after the Close of Business on Wednesday, June 8, 2005.
Next Article:Fraxel Laser Treatment Offers Patients Full-Body Solution To Restore Aging and Sun Damaged Skin; Leading Aesthetic Surgeons at Major Medical Meetings...
Topics:



Related Articles
Lilly in Full Bloom with $531 Million in Biotech Construction Underway in Indianapolis, an Advisory from Industrialinfo.com.
Cook Pharmacia Hires Contractor to Build $45 Million Biotech Plant on Site of Closed Electronics Factory in Indiana, An Advisory by...
$45 Billion Biotech Industry Kicks Off BIO2004 in San Francisco Drawing Moguls and Militants, an Advisory from Industrialinfo.com.
BIO2004 Breakfast Session With Biotech's Best and Brightest, an Advisory From Industrialinfo.com.
BioHouston: DeBakey Sees Houston As Sure Fit for Biotech, an Advisory from Industrialinfo.com.
3Q05 Maintenance Expenditures for U.S. Industrials Exceed $700 Million, an Advisory from Industrialinfo.com.
Biotech Company Gets Piggy, Considers Wisconsin Sites for New Plant Construction, an Advisory from Industrialinfo.com.
Whiting-Turner Contracting Leverages High-Tech Industrial Experience to Win Nanoscale Research Facility Construction Management Contract in Florida,...
Anatomy of a Pharmaceutical Plant: Second in a 3-Part Series Examining the Financial Impact of New Plant Construction, an Advisory from...
Anatomy of a Pharmaceutical Plant: Final of a 3-part Series Examining the Financial Impact of New Plant Construction, an Advisory from...

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles